Title |
Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study
|
---|---|
Published in |
Nutrition Journal, September 2013
|
DOI | 10.1186/1475-2891-12-127 |
Pubmed ID | |
Authors |
Yuko Tousen, Mariko Uehara, Fumiko Abe, Yoshifumi Kimira, Yoshiko Ishimi |
Abstract |
Recent studies suggest that some of the clinical effectiveness of soy or daidzein, which is a type of isoflavone, may be attributed to a person's ability to produce equol from daidzein. Equol, which is a metabolite of one of the major soybean isoflavones called daidzein, is produced in the gastrointestinal tract by certain intestinal microbiota where present. Habitual dietary patterns may alter the intestinal bacterial profile, and influence the metabolism of isoflavones and the production of equol. Fructooligosaccharides (FOS) have a prebiotic activity as well as being a dietary fibre. The purpose of the present study was to determine whether FOS supplementation increases equol production in equol producers and stimulates equol production in equol non-producers in Japanese postmenopausal women. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | <1% |
Australia | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 140 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 37 | 26% |
Student > Master | 29 | 20% |
Researcher | 15 | 10% |
Student > Ph. D. Student | 6 | 4% |
Other | 5 | 3% |
Other | 17 | 12% |
Unknown | 34 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 27 | 19% |
Medicine and Dentistry | 27 | 19% |
Nursing and Health Professions | 14 | 10% |
Biochemistry, Genetics and Molecular Biology | 9 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
Other | 19 | 13% |
Unknown | 41 | 29% |